ARCHIVES

Major Changes In NCI Drug screening Tumor Panels Approved

This article is from The Cancer Letter archive.

Vol. 08 No. 25 | June 18, 1982

Download PDF Visit The Full Archive

Related Articles

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

September 7, 1990

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996